研究業績
- 英 文
- 和 文
-
22 Yoshino A,Okamoto Y,Yamawaki S. Neuroimaging studies about the relationship between negative emotions and pain. PAIN RESEARCH.2020 May,35(1):17-23.doi: 10.11154/pain.35.17 21 Yamada T, Hashimoto R, Yahata N, Ichikawa N, Okamoto Y, Kato N, Takahashi H, Kawato M. : Resting-state functional connectivity-based biomarkers and functional MRI-based neurofeedback for psychiatric disorders: a challenge for novel diagnosis and treatment.Internatinnal Joutnal of Neuropsychopharmacology 20 : 769-781, 2017. 20 Suhara T, Walton NM, Yamawaki S. et al. : Strategies for utilizing neuroimaging biomarkers in CNS drug discovery and development: CINP/JSNP working group report. International Journal of Neuropsychopharmacology 20 : 285-2947, 2017. 19 Shibasaki C, Itagaki K, Abe H, Kajitani N, Okada-Tsuchioka M, Takebayashi M. : Possible Association between Serum Matrix Metalloproteinase-9 (MMP-9) Levels and Relapse in Depressed Patients following Electroconvulsive Therapy (ECT). Internatinnal Journal Neuropsychopharmacology. 2017 Sep 16. 18 Itagaki K, Takebayashi M, Shibasaki C, Kajitani N, Abe H, Okada-Tsuchioka M, Yamawaki S. : Factors associated with relapse after a response to electroconvulsive therapy in unipolar versus bipolar depression. Journal of Affective Disorder, 208 : 113-119, 2017. 17 Hisaoka-Nakashima K, Matsumoto C, Azuma H, Taki S, Takebayashi M, Nakata Y, Morioka N. : Pharmacological Activation Gi/o Protein Increases Glial Cell Line-Derived Neurotrophic Factor Production through Fibroblast Growth Factor Receptor and Extracellular Signal-Regulated Kinase Pathway in Primary Cultured Rat Cortical Astrocytes. Biological and Pharmaceutical Bulletin 40 : 1759-1766, 2017. 16 Uchida H, Yamawaki S, Bahk WM, Jon DI. : Neuroscience-based nomenclature (NbN) for clinical psychopharmacology and neuroscience. Clinical Psychopharmacology and Neuroscience 14 : 115-116, 2016. 15 Shibasaki C, Takebayashi M, Itagaki K, Abe H, Kajitani N, Okada-Tsuchioka M, Yamawaki S. : Altered Serum Levels of Matrix Metalloproteinase-2, -9 in Response to Electroconvulsive Therapy for Mood Disorders. International Journal of Neuropsychopharmacology 19, 2016. 14 Kajitani N, Miyano K, Okada-Tsuchioka M, Abe H, Itagaki K, Hisaoka-Nakashima K, Morioka N, Uezono Y, Takebayashi M. : Identification of lysophosphatidic acid receptor 1 in astroglial cells as a target for glial cell line- derived neurotrophic factor expression induced by antidepressants. Journal of Biological Chemistry 291 : 27364- 27370, 2016. 13 Hisaoka-Nakashima K, Kajitani N, Kaneko M, Shigetou T, Kasai M, Matsumoto C, Yokoe T, Azuma H, Takebayashi M, Morioka N, Nakata Y. : Amitriptyline induces brain-derived neurotrophic factor (BDNF) mRNA expression through ERK-dependent modulation of multiple BDNF mRNA variants in primary cultured rat cortical astrocytes and microglia. Brain Research 1634 : 57-67, 2016. 12 Fuchikami M, Yamamoto S, Morinobu S, Okada S, Yamawaki Y, Yamawaki S. : The potential use of histone deacetylase inhibitors in the treatment of depression. Progress in Neuro-Psychopharmacology and Biological Psychiatry 64 : 320-324, 2016. 11 Abe H, Hisaoka-Nakashima K, Kajitani N, Okada-Tsuchioka M, Yano R, Itagaki K, Shibasaki C, Morioka N, Nakata Y, Takebayashi M. : The expression of glial cell line-derived neurotrophic factor mRNA by antidepressants involves matrix metalloproteinase-9 activation in rat astroglial cells. Biochemical and Biophysical Research Communications, 479 : 907-912, 2016. 10 10. Zohar,J., Stahl,S., Moller,HJ., Blier,P., Kupfer,D., Yamawaki,S., Uchida,H., Speeding,M., Goodwin,G., Nutt,D. : A review of the current nomenclature for psychotropic agents and an introduction to the neuroscience-based nomenclature. European Neuropsychopharmacology 25: 2318-2325, 2015. 9 Yamawaki,S., Okada,G., Okamoto,Y., Liberzon,I. : Mood dysregulation and stabilization: Perspectives from emotional cognitive neuroscience. International Journal of Neuropsychopharmacology 17: 1-14, 2011. 8 Fuchikami,M., Yamamoto,S., Morinobu,S., Takei,S., Yamawaki,S. : Epigecetic regulation of BDNF gene in response to stress. Psychiatry Investigation 7: 251-256, 2010. 7 Nishida,A., Hisaoka,K., Zensho,H., Uchitomi,Y., Morinobu,S., Yamawaki,S. : Antidepressant drugs and cytokines in mood disorders. International Immunopharmacology 2: 1619-1626, 2002. 6 Nishida,A., Hisaoka,K., Morinobu,S., Yamwaki,S. : Genetic research of mood disorders. Current Topics in Neurochemistry 3: 116-121, 2002. 5 Nakae,S., Kagaya,A., Katagiri,H., Jitsuiki,H., Fukumoto,T., Tamura,T., Kouhata,S., Morinobu,S., Sasa,M., Yamawaki,S. : Serotonin-2A receptor and the receptor-mediated signaling systems in rats: possible implication for pathophysiology of mood disorders. Current Topics in Neurochemistry 3: 83-95, 2002. 4 Yamawaki,S. : Psychopharmacology of serotonin in mood disorders. Singapore Medical Journal 41(Suppl): 5-9, 2000. 3 Yamawaki,S. : The use and development of anxiolytics in Japan. European Neuropsychopharmacology 9(Suppl.6): S413-S419, 1999. 2 Nishida,A., Zensho,H., Hisaoka,K., Okamoto,Y., Uchitomi,Y., Yamawaki,S. : Molecular mechanisms of alcoholism in the nervous system. Recent Res. Devel. Neurochem. 2: 139-155, 1999. 1 Yamawaki,S., Kagaya,A., Tawara,Y., Inagaki,M. : Intracellular calcium mechanism in the pathophysiology of affective disorders. Life Sciences 62: 1665-1670, 1998.